Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer's Disease Patients?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  CNS and Neurological Disorders - Drug Targets

• Publication date

  2016-07-31

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2174/1871527315666160518123201PMID 27189470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of 18F‐fluorodeoxyglucose metabolism in rat brain frontal cortex using a β3 adrenoceptor agonist

  2015cited by this paper
• Norepinephrine Protects against Amyloid-β Toxicity via TrkB

  2015cited by this paper
• Autonomic Dysfunction in Alzheimer's Disease: Tools for Assessment and Review of the Literature

  2014cited by this paper
• Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome.

  2014cited by this paper
• Beta-adrenergic antagonist effects on a novel cognitive flexibility task in rodents.

  2014cited by this paper
• Noradrenergic blockade and memory in patients with major depression and healthy participants.

  2014cited by this paper
• Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice.

  2013cited by this paper
• Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

  2013influential reference
• Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.

  2013cited by this paper
• β2 Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models*

  2013cited by this paper
• Antihypertensive medication use and risk of cognitive impairment

  2013cited by this paper
• Environmental novelty activates β2-adrenergic signaling to prevent the impairment of hippocampal LTP by Aβ oligomers.

  2013cited by this paper
• Adrenergic signaling and oxidative stress: a role for sirtuins?

  2013cited by this paper
• Noradrenergic Sympathetic Sprouting and Cholinergic Reinnervation Maintains Non-Amyloidogenic Processing of AβPP

  2013cited by this paper
• β-Adrenergic Receptors and G Protein-Coupled Receptor Kinase-2 in Alzheimer's Disease: A New Paradigm for Prognosis and Therapy?

  2013cited by this paper
• The deletion variant of α2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment.

  2013cited by this paper
• Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis

  2013cited by this paper
• Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease.

  2013cited by this paper
• Investigation of Nebivolol as a Novel Therapeutic Agent for the Treatment of Alzheimer's Disease

  2013cited by this paper
• Exercise-Induced Noradrenergic Activation Enhances Memory Consolidation in Both Normal Aging and Patients with Amnestic Mild Cognitive Impairment

  2012cited by this paper
• Behavioral and cellular markers of olfactory aging and their response to enrichment.

  2012cited by this paper
• Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.

  2012cited by this paper
• GRK2 inhibition in heart failure: something old, something new.

  2012cited by this paper
• Agonistic Autoantibodies to the α1‐Adrenergic Receptor and the β2‐Adrenergic Receptor in Alzheimer’s and Vascular Dementia

  2012cited by this paper
• The Locus Coeruleus-Norepinephrine Network Optimizes Coupling of Cerebral Blood Volume with Oxygen Demand

  2012cited by this paper
• Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice.

  2011cited by this paper
• Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.

  2011cited by this paper
• Long-Term α1A-Adrenergic Receptor Stimulation Improves Synaptic Plasticity, Cognitive Function, Mood, and Longevity

  2011cited by this paper
• Carvedilol as a potential novel agent for the treatment of Alzheimer's disease.

  2011cited by this paper
• Quantitative assessment of brown adipose tissue metabolic activity and volume using 18F-FDG PET/CT and β3-adrenergic receptor activation

  2011cited by this paper
• Amyloid Peptide-(1-42) Induces Internalization and Degradation of 2 Adrenergic Receptors in Prefrontal

  2011cited by this paper
• Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production.

  2010cited by this paper
• Binding of amyloid β peptide to β2 adrenergic receptor induces PKA‐dependent AMPA receptor hyperactivity

  2010cited by this paper
• The locus coeruleus and noradrenergic modulation of cognition

  2009cited by this paper
• Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.

  2009cited by this paper
• Future G protein-coupled receptor targets for treatment of heart failure

  2009cited by this paper
• Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.

  2008cited by this paper
• Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.

  2008cited by this paper
• Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease.

  2007cited by this paper
• Amyloid beta-protein1-42 increases cAMP and apolipoprotein E levels which are inhibited by β1 and β2-adrenergic receptor antagonists in mouse primary astrocytes

  2006cited by this paper
• Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice

  2006cited by this paper
• The Locus Ceruleus Is Involved in the Successful Retrieval of Emotional Memories in Humans

  2006cited by this paper
• Amyloid beta-protein1-42 increases cAMP and apolipoprotein E levels which are inhibited by beta1 and beta2-adrenergic receptor antagonists in mouse primary astrocytes.

  2006cited by this paper
• Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation.

  2006cited by this paper
• Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's.

  2004cited by this paper
• Noradrenergic action in prefrontal cortex in the late stage of memory consolidation.

  2004cited by this paper
• Noradrenergically mediated plasticity in a human attentional neuronal network.

  1999cited by this paper
• Stimulation of amyloid precursor protein synthesis by adrenergic receptors coupled to cAMP formation.

  1997cited by this paper
• Altered beta-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors.

  1993cited by this paper
• Alterations in adrenergic receptors of frontal cortex and cerebral microvessels in Alzheimer's disease and aging.

  1989cited by this paper
• Adrenergic Receptors in Aging and Alzheimer's Disease: Increased β2‐Receptors in Prefrontal Cortex and Hippocampus

  1989cited by this paper
• Changes in beta-adrenergic receptor subtypes in Alzheimer-type dementia.

  1987cited by this paper
• Acute desensitization of lymphocyte beta-adrenergic-stimulated adenylate cyclase in old age and Alzheimer's disease.

  1984cited by this paper

• One-trial appetitive learning tasks for drug targeting.

  2023cites this paper
• Carvedilol promotes retinal ganglion cell survival following optic nerve injury via ASK1-p38 MAPK pathway.

  2020cites this paper
• Monoamines and their derivatives on GPCRs: potential therapy for Alzheimer's Disease.

  2019cites this paper
• Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease.

  2019cites this paper
• Early Electrophysiological Disintegration of Hippocampal Neural Networks in a Novel Locus Coeruleus Tau-Seeding Mouse Model of Alzheimer's Disease

  2019cites this paper
• Emodin attenuates Alzheimer's disease by activating the protein kinase C signaling pathway.

  2019cites this paper
• Trigeminal, Visceral and Vestibular Inputs May Improve Cognitive Functions by Acting through the Locus Coeruleus and the Ascending Reticular Activating System: A New Hypothesis

  2018cites this paper
• Neurophysiological assessment of neural network plasticity and connectivity: Progress towards early functional biomarkers for disease interception therapies in Alzheimer's disease

  2017cites this paper
• The Longevity of Hippocampus-Dependent Memory Is Orchestrated by the Locus Coeruleus-Noradrenergic System

  2017cites this paper
• Aging, defined as “increasing mortality with increas- ing chronological age in populations in the wild” [1], also known as “actuarial senescence in the wild” [2], or “pro- gressive loss of function accompanied by decreasing fer-

  2016cites this paper
• Possible interventions to modify aging

  2016cites this paper